EichorEICHOR
Condition: Locally Advanced Gastric Carcinoma Synced from ClinicalTrials.gov · August 06, 2026

Recruiting studies: Locally Advanced Gastric Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

First-Line and Neoadjuvant Immunotherapy for Gastric Cancer
Phase N/A · 1 location(s) · Qilu Hospital of Shandong University · NCT06727981XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.
Phase 1/Phase 2 · 1 location(s) · Evopoint Biosciences Inc. · NCT06792435Personalized DC Vaccine for Postoperative Cancer
Phase 1 · 1 location(s) · Sichuan University · NCT04147078Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Canc
Phase 2 · 5 location(s) · Xijing Hospital · NCT06576921Tislelizumab in Combination With Pre-operative CRT Versus SOC for Locally Advanced G/GEJ Adenocarcinoma
Phase 2 · 3 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT05687357Albumin-bound Paclitaxel-based Second-line Treatment Regimens for Locally Advanced or Metastatic G/GEJ Adenocarcinoma
Phase N/A · 1 location(s) · Fudan University · NCT07389876Prediction of Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric Cancer
NA · 1 location(s) · Ruijin Hospital · NCT05140746Perioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer
Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT07325630Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancre
Phase 2 · 1 location(s) · OHSU Knight Cancer Institute · NCT05705492Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
Phase 1/Phase 2 · 19 location(s) · Yuhan Corporation · NCT05523947Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC
Phase 2 · 1 location(s) · Peking University · NCT06023758Proximal Versus Total Gastrectomy for Locally Advanced Siewert Type II-III Gastroesophageal Junction Cancer
NA · 1 location(s) · Nurettin Şahin · NCT07482566A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Phase 1/Phase 2 · 14 location(s) · Astellas Pharma Global Development, Inc. · NCT07488676A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
Phase 3 · 1 location(s) · Astellas Pharma Global Development, Inc. · NCT07673887Study of Comparing of With and Without Sequential Therapy of S-1
Phase 3 · 1 location(s) · Zhejiang University · NCT05813015A Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer Patients
Phase 3 · 1 location(s) · Suzhou Immunofoco Biotechnology Co., Ltd · NCT07103668Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and PD-L1-Positive Gastric or Esophagog
Phase 2 · 18 location(s) · National Cancer Center, Japan · NCT07699939Comparison of Laparoscopic and Open Total Gastrectomy for Locally Advanced Gastric Cancer
NA · 3 location(s) · University Medical Center Ho Chi Minh City (UMC) · NCT06202105Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer
Phase 2 · 1 location(s) · Jeeyun Lee · NCT06630130Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)
Phase N/A · 9 location(s) · Qun Zhao · NCT07401199A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal
Phase 3 · 208 location(s) · Shanghai Henlius Biotech · NCT06532006A Study of SH009 Injection in Patients With Advanced Solid Tumors.
Phase 1 · 1 location(s) · Nanjing Sanhome Pharmaceutical, Co., Ltd. · NCT07390838A Long-term Follow-up Study of Subjects Enrolled in Clinical Trials of Cadonilimab (AK104)
Phase N/A · 1 location(s) · Akeso · NCT07547787DBC-664 in Adult Patients With Solid Tumors
Phase 1 · 3 location(s) · Duboce Biopharmaceuticals, Inc. · NCT07705035Standard Versus Super-extended Lymphadenectomy After Neo-adjuvant Chemotherapy for Gastric Cancer
Phase 3 · 1 location(s) · University of Siena · NCT03961373Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer
Phase 2 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06510010Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.
Phase 2 · 11 location(s) · RemeGen Co., Ltd. · NCT06155383SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer
Phase 2 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT07464756Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Meta
Phase 1/Phase 2 · 42 location(s) · Inhibrx Biosciences, Inc · NCT04198766A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Phase 3 · 249 location(s) · Astellas Pharma Global Development, Inc. · NCT06901531
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.